enVVeno Medical: Pay

enVVeno Medical paid its 2 named executives $1.2M in total in FY2024 (Dec). CEO Robert A. Berman was paid $1.2M of that.

Pay$100 in the stock at the end of FY21 → $46
CEO pay is from each proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Pay of each named executive

Robert A. BermanChief Executive Officer
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)
3 years
Marc H. Glickman, M.D.Chief Medical Officer and Senior Vice President
FY2023 (Dec)
FY2022 (Dec)
2 years
Dr. Hamed AlaviSenior Vice President & Chief Technology Officer
FY2023 (Dec)
FY2022 (Dec)
2 years
Craig GlynnFormer Chief Financial Officer
FY2023 (Dec)
FY2022 (Dec)
2 years
Jennifer BrightChief Financial Officer
FY2024 (Dec)
1 year

Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.